CClinicalTrials.gg
CompletedNCT02727478BETA-PDUpdated Aug 14, 2023Results posted

Effectiveness and Implementation of the HiBalance Program in Clinical Practice

An interventional study of HiBalance training program in Parkinson Disease, sponsored by Karolinska Institutet. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-08-14.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
117
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This effectiveness-implementation study is a part of the larger study BETA-PD (Balance, Elderly, Training and Activity in Parkinson's Disease), which has the long-term goal to reduce the risk of falling in people with Parkinson's disease (PD) by improving balance, gait and physical activity level. The main hypothesis is that highly challenging balance training will lead to greater gait and balance ability, increased levels of physical activity and an improved health related quality of life. The main aims of the study are to evaluate the effectiveness of the HiBalance program in real-life clinical settings, while exploring facilitators and barriers for program implementation on a wider scale.

Read the detailed description

The clinical features of PD include progressive postural instability, hypokinesia, tremor and rigidity. It is therefore common that people with PD experience reduced balance and gait function, symptoms which can have far-reaching negative effects on their health and quality of life. Injurious falls and fear of falling are especially prevalent among those with PD, a factor which may partly explain why this group are less physically active than older people of a similar age without the diagnosis. Balance and gait training, on the other hand, have been shown effective in PD and also appear to have potential neuro-protective properties. Research in the area of balance training in PD disease however is sparse and previous interventions have been criticized for applying training stimuli which lacked intensity and challenge.

The HiBalance program is based on scientifically well-established principles of exercise training and postural control as well as current research on training in PD. The program was developed to affect symptom-specific balance impairments in PD by targeting four main subsystems underlying balance control (stability limits, anticipatory postural adjustments, sensory integration and motor agility). The intervention consists of a 10-week progressive balance training program in group format (5-7 participants). Each training session is conducted by a minimum of 2 physiotherapist trainers, during twice weekly 1-hour sessions (20 hours in total). Additionally, a home-exercise program is carried out by the participants once a week during the trial period. The difficulty level of the group-based training is increased in three consecutive blocks. To ensure highly challenging exercises, each task is individually adjusted by altering the area of base of support, increasing movement speed/amplitude and/or restricting vision and varying the grade of multitasking. The program has previously been proven feasible [Conradsson, 2012] and effective [Conradsson, 2015] in improving balance and gait impairments in a randomized controlled hospital setting. In addition, favorable transfer effects were seen in relation to physical activity levels and the performance of activities of everyday life.

For research interventions to be adopted in real-life clinical settings however a level of adaptation is required. Best practice then involves evaluating the effectiveness of efficacious programs in clinical settings, in order to verify whether or not the adaptation has attenuated the effective core elements of the program itself.

The current study combines a clinical effectiveness trial together with implementation research. Use of a type-1 hybrid design will allow the effects of the HiBalance program in clinical settings to be tested while simultaneously gathering information on barriers and facilitators to the implementation process [Curran, 2012]. Use of the hybrid design also allows for constant monitoring of the process by which the intervention is applied, and therefore allow problems in early application to be identified and quickly altered so as to ensure better outcomes. A participatory approach will be adhered to whereby 'users' of the program (physiotherapist trainers) will be actively involved in all stages of the program adaptation, process and outcome evaluation. This approach is recommended in order to increase the relevance, acceptability and successful implementation of the program. The Consolidated Framework for Implementation Research (CFIR) will be used in the current study to guide the investigation of potential barriers to and facilitators of the implementation process [Damschroder, 2009 ].

02

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • Balance
  • Rehabilitation
  • Exercise
  • basal ganglia
  • Gait
  • Training
  • physical activity
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 117 is above the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed idiopathic Parkinson's Disease
  • Measured balance impairment (according to the mini-BESTest)
  • Hoehn and Yahr stages 2-3
  • Independent ambulator indoors without a walking aid

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment which hinders participation in group training
  • The presence of comorbidities which hinder safe participation in group training
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
117 participants (actual)

Study arms

  • Experimental
    Balance training group

    1 hour group balance training twice weekly for 10 weeks, as well as perform a home exercise program.

    Other: HiBalance training program

  • No intervention
    Control group

    Subjects in this group will receive no intervention and will be advised to continue their normal level of exercise throughout the intervention period.

Interventions

  • OtherHiBalance training program

    The program consists of physiotherapist led highly challenging balance exercises, which are adapted and progressed on both a group and individual basis throughout the training period.

06

What researchers measure

Primary outcomes

  1. Change in Mini-BESTest Score From Baseline at 1 Week Post Intervention.

    Mini-Balance Evaluation Systems Test a rating scale for dynamic balance incorporating 14 different balance and gait items that were assessed by a physical therapist on a scale from 0-2. Maximum points 28. 0-28 points with higher scores indicating better balance control The mini-BESTest is an assessment of balance performance and will be performed by the physiotherapists in the respective clinics.

    Time frame: Change in Mini-BESTest score from baseline at 1 week post intervention.

Secondary outcomes

  1. Change in 10-meter Walking Test Score From Baseline at 1 Week Post Intervention.

    The 10-meter walking test assesses gait performance was performed by the physiotherapists in the respective clinics. Gait speed was measured as m/sec during 10 meters

    Time frame: From baseline at 1 week post intervention.

  2. Change in Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.

    The TUG test assesses functional mobility and will be performed by the physiotherapists in the respective clinics. TUG test measures performance of a sequential locomotor task (rising from a chair, walking 3 m, turning and walking back to the chair). Timed Up and Go (TUG) test is measured in seconds it takes to perform the task.

    Time frame: From baseline at 1 week post intervention.

  3. Change in EQ-5D Score From Baseline at 1week Post Intervention.

    The EQ-5D is a 2-paged form assessing health-related quality of life and will be filled in by participants. European Quality of Life- 5 dimensions (EQ-5D), The visual analogue scale (VAS) indicates the general health status ranging from 0-100 with 100 indicating the best health status

    Time frame: From baseline at 1week post intervention.

  4. Change in Activities-specific Balance Confidence (ABC) Scale

    The ABC scale assesses self-reported balance confidence and will be filled in by study participants. It consists of 16 items that are rated from from 0-100% where 0% indicates no confidence and 100% complete confidence. The overall score is calculated by adding the item scores and dividing the total by 16 (i.e. the number of items). This total score ranges from 0% to 100%.

    Time frame: From baseline at 1 week post intervention.

  5. Change in Physical Activity Level From Baseline 1 Week Post Intervention.

    Participants will wear accelerometers for a 7-day period directly before and after the intervention. Physical activity level (steps per day)

    Time frame: from baseline to 1 week post intervention

  6. Change in Dual Task Interference During the Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.

    The TUG test assesses functional mobility and will be performed by the physiotherapists in the respective clinics. TUG test measures performance of a sequential locomotor task (rising from a chair, walking 3 m, turning and walking back to the chair).The TUG COG test involves performance of the TUG test while sequentially subtracting the number 3 from a start number. The time difference between the TUG and the TUG COG reflects dual-task interference during functional mobility and is calculated be expressed as a percentage: (TUG COG - TUG)/TUG.

    Time frame: From baseline at 1 week post intervention.

07

Results

Posted Aug 14, 2023

Participant flow

Participant flow — Overall Study
MilestoneBalance Training GroupControl Group
Started6156
Completed5346
Not completed810
Withdrew: Withdrawal by subject810

Outcome measures

PrimaryChange in Mini-BESTest Score From Baseline at 1 Week Post Intervention.

Mini-Balance Evaluation Systems Test a rating scale for dynamic balance incorporating 14 different balance and gait items that were assessed by a physical therapist on a scale from 0-2. Maximum points 28. 0-28 points with higher scores indicating better balance control The mini-BESTest is an assessment of balance performance and will be performed by the physiotherapists in the respective clinics.

Time frame:
Change in Mini-BESTest score from baseline at 1 week post intervention.
Reported as:
Mean · score on a scale
Change in Mini-BESTest Score From Baseline at 1 Week Post Intervention.
score on a scaleBalance Training GroupControl Group
Change in Mini-BESTest Score From Baseline at 1 Week Post Intervention.2.0 ± 2.0-0.2 ± 2.4
Statistical analysis
  • Balance Training Group vs Control Group · ANOVA · p = < 0.001
SecondaryChange in 10-meter Walking Test Score From Baseline at 1 Week Post Intervention.

The 10-meter walking test assesses gait performance was performed by the physiotherapists in the respective clinics. Gait speed was measured as m/sec during 10 meters

Time frame:
From baseline at 1 week post intervention.
Reported as:
Mean · m/sec
Change in 10-meter Walking Test Score From Baseline at 1 Week Post Intervention.
m/secBalance Training GroupControl Group
Change in 10-meter Walking Test Score From Baseline at 1 Week Post Intervention.0.2 ± 0.41-0.04 ± 0.14
Statistical analysis
  • Balance Training Group vs Control Group · ANOVA · p = =0.001
SecondaryChange in Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.

The TUG test assesses functional mobility and will be performed by the physiotherapists in the respective clinics. TUG test measures performance of a sequential locomotor task (rising from a chair, walking 3 m, turning and walking back to the chair). Timed Up and Go (TUG) test is measured in seconds it takes to perform the task.

Time frame:
From baseline at 1 week post intervention.
Reported as:
Median · seconds
Change in Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.
secondsBalance Training GroupControl Group
Change in Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.-0.4 (-1.13 to 0.5)0 (-1.6 to 1.2)
Statistical analysis
  • Balance Training Group vs Control Group · Wilcoxon (Mann-Whitney) · p = 0.254
SecondaryChange in EQ-5D Score From Baseline at 1week Post Intervention.

The EQ-5D is a 2-paged form assessing health-related quality of life and will be filled in by participants. European Quality of Life- 5 dimensions (EQ-5D), The visual analogue scale (VAS) indicates the general health status ranging from 0-100 with 100 indicating the best health status

Time frame:
From baseline at 1week post intervention.
Reported as:
Median · units on a scale
Change in EQ-5D Score From Baseline at 1week Post Intervention.
units on a scaleBalance Training GroupControl Group
Change in EQ-5D Score From Baseline at 1week Post Intervention.5.5 (-5 to 15)0 (-10 to 5)
Statistical analysis
  • Balance Training Group vs Control Group · Wilcoxon (Mann-Whitney) · p = =0.065
SecondaryChange in Activities-specific Balance Confidence (ABC) Scale

The ABC scale assesses self-reported balance confidence and will be filled in by study participants. It consists of 16 items that are rated from from 0-100% where 0% indicates no confidence and 100% complete confidence. The overall score is calculated by adding the item scores and dividing the total by 16 (i.e. the number of items). This total score ranges from 0% to 100%.

Time frame:
From baseline at 1 week post intervention.
Reported as:
Median · units on a scale
Change in Activities-specific Balance Confidence (ABC) Scale
units on a scaleBalance Training GroupControl Group
Change in Activities-specific Balance Confidence (ABC) Scale68 ± 16.970 ± 18.2
Statistical analysis
  • Balance Training Group vs Control Group · ANOVA · p = =0.301
SecondaryChange in Physical Activity Level From Baseline 1 Week Post Intervention.

Participants will wear accelerometers for a 7-day period directly before and after the intervention. Physical activity level (steps per day)

Time frame:
from baseline to 1 week post intervention
Reported as:
Mean · steps per day
Change in Physical Activity Level From Baseline 1 Week Post Intervention.
steps per dayBalance Training GroupControl Group
Change in Physical Activity Level From Baseline 1 Week Post Intervention.-288 ± 1428-390 ± 2016
Statistical analysis
  • Balance Training Group vs Control Group · ANOVA · p = =0.792
SecondaryChange in Dual Task Interference During the Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.

The TUG test assesses functional mobility and will be performed by the physiotherapists in the respective clinics. TUG test measures performance of a sequential locomotor task (rising from a chair, walking 3 m, turning and walking back to the chair).The TUG COG test involves performance of the TUG test while sequentially subtracting the number 3 from a start number. The time difference between the TUG and the TUG COG reflects dual-task interference during functional mobility and is calculated be expressed as a percentage: (TUG COG - TUG)/TUG.

Time frame:
From baseline at 1 week post intervention.
Reported as:
Median · percentage of interference
Change in Dual Task Interference During the Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.
percentage of interferenceBalance Training GroupControl Group
Change in Dual Task Interference During the Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention.-1.22 (-6.2 to 0.66)1.05 (-3.07 to 3.51)
Statistical analysis
  • Balance Training Group vs Control Group · Wilcoxon (Mann-Whitney) · p = 0.039

Adverse events

Collected over 10 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Balance Training Group0/61 (0%)0/61 (0%)12/61 (19.7%)
Control Group———
Most frequent other events
Most frequent other events
EventBalance Training GroupControl Group
FallsInjury, poisoning and procedural complications12/61—

Baseline characteristics

Age, Continuous
Age, Continuous(years)Balance Training GroupControl GroupTotal
Mean70 ± 8.570 ± 6.570. ± 7.6
Sex: Female, Male
Sex: Female, Male(Participants)Balance Training GroupControl GroupTotal
Female332255
Male283462
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Balance Training GroupControl GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White000
More than one race000
Unknown or Not Reported6156117
08

Study locations

1 site
  • Karolinska institutet
    Stockholm, Södermanland 14183, Sweden
09

References and documents

Publications

  • Conradsson D, Lofgren N, Stahle A, Hagstromer M, Franzen E. A novel conceptual framework for balance training in Parkinson's disease-study protocol for a randomised controlled trial. BMC Neurol. 2012 Sep 27;12:111. doi: 10.1186/1471-2377-12-111. PubMed 23017069 ↗
  • Conradsson D, Lofgren N, Nero H, Hagstromer M, Stahle A, Lokk J, Franzen E. The Effects of Highly Challenging Balance Training in Elderly With Parkinson's Disease: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2015 Oct;29(9):827-36. doi: 10.1177/1545968314567150. Epub 2015 Jan 21. PubMed 25608520 ↗
  • Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812. PubMed 22310560 ↗
  • Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4:50. doi: 10.1186/1748-5908-4-50. PubMed 19664226 ↗
  • Leavy B, Joseph C, Lofgren N, Johansson H, Hagstromer M, Franzen E. Outcome Evaluation of Highly Challenging Balance Training for People With Parkinson Disease: A Multicenter Effectiveness-Implementation Study. J Neurol Phys Ther. 2020 Jan;44(1):15-22. doi: 10.1097/NPT.0000000000000298. PubMed 31834166 ↗
  • Leavy B, Joseph C, Kwak L, Franzen E. Implementation of highly challenging balance training for Parkinson's disease in clinical practice: a process evaluation. BMC Geriatr. 2021 Feb 1;21(1):96. doi: 10.1186/s12877-021-02031-1. PubMed 33526031 ↗
  • Leavy B, Kwak L, Hagstromer M, Franzen E. Evaluation and implementation of highly challenging balance training in clinical practice for people with Parkinson's disease: protocol for the HiBalance effectiveness-implementation trial. BMC Neurol. 2017 Feb 7;17(1):27. doi: 10.1186/s12883-017-0809-2. PubMed 28173775 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 2, 2016

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02727478
Lead sponsor
Karolinska Institutet
Collaborators
Karolinska University Hospital
Responsible party
Erika Franzén (Associate Professor, Karolinska Institutet) — Principal investigator
First posted
Apr 4, 2016
Start date
Mar 28, 2016
Primary completion
Feb 20, 2018
Completion
Sep 28, 2018
Results posted
Aug 14, 2023
Last update
Aug 14, 2023

Study contacts

Erika Franzén, PhD
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion